Investing Profile

Mark Jelley

InvestorVC
Partner at OrbiMed
orbimed.comNew York, New York
Photo of Mark Jelley, Partner at OrbiMed

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Duke University Network
195 CONNECTIONS
UBS Network
186 CONNECTIONS
UBS Investment Bank Network
52 CONNECTIONS
Macquarie Group Network
51 CONNECTIONS
Macquarie Group Network
51 CONNECTIONS
cb
OrbiMed Partner
$1M - $75.0M
$4.0M
3
$18B
CompanyStageDateRound SizeTotal Raised
Caris Life Sciences
Debt FinancingJan 2023$400M
Series UnknownOct 2020$240M
$800M
Co-investors: Narendra Nayak (Deerfield Management)
DarioHealth
Post Ipo DebtJun 2022$50M
$50M
Analyst, Principal Investing Macquarie GroupPresent
Analyst Macquarie GroupPresent
Financial Sponsors and Leveraged Finance Group UBSPresent
Financial Sponsors and Leveraged Finance Group UBS Investment BankPresent
Board Observer NateraPresent
Managing Director OrbiMedPresent
Board Member HLS Therapeutics Inc.Present
Board Observer Guardant HealthPresent
Board Observer ValnevaPresent
Board Observer AbCelleraPresent
Board Observer Caris Life SciencesPresent
Board Observer VariantyxPresent
Partner OrbiMedPresent
Duke University BS Chemistry, Biology